$AMS
AMERICAN SHARED HOSPITAL SERVICES

2020 Q2 Form 10-Q Financial Statement

#000074482520000093 Filed on August 14, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $3.991M $5.197M
YoY Change -23.21% 0.54%
Cost Of Revenue $3.084M $3.468M
YoY Change -11.07% 12.31%
Gross Profit $907.0K $1.729M
YoY Change -47.54% -16.91%
Gross Profit Margin 22.73% 33.27%
Selling, General & Admin $1.210M $1.081M
YoY Change 11.93% 4.75%
% of Gross Profit 133.41% 62.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.671M $2.023M
YoY Change -17.4% 20.42%
% of Gross Profit 184.23% 117.0%
Operating Expenses $1.210M $1.081M
YoY Change 11.93% 4.75%
Operating Profit -$570.0K $302.0K
YoY Change -288.74% -53.03%
Interest Expense $267.0K $346.0K
YoY Change -22.83% -14.78%
% of Operating Profit 114.57%
Other Income/Expense, Net
YoY Change
Pretax Income -$569.0K $306.0K
YoY Change -285.95% -54.26%
Income Tax -$130.0K $27.00K
% Of Pretax Income 8.82%
Net Earnings -$483.0K $31.00K
YoY Change -1658.06% -89.2%
Net Earnings / Revenue -12.1% 0.6%
Basic Earnings Per Share -$0.08 $0.01
Diluted Earnings Per Share -$0.08 $0.01
COMMON SHARES
Basic Shares Outstanding 6.008M 5.876M shares
Diluted Shares Outstanding 6.077M 5.906M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.045M $1.906M
YoY Change 112.22% -45.39%
Cash & Equivalents $4.045M $1.906M
Short-Term Investments
Other Short-Term Assets $1.138M $994.0K
YoY Change 14.49% 1.43%
Inventory
Prepaid Expenses
Receivables $5.472M $6.565M
Other Receivables $168.0K $481.0K
Total Short-Term Assets $10.82M $9.946M
YoY Change 8.82% 1.86%
LONG-TERM ASSETS
Property, Plant & Equipment $40.30M $43.53M
YoY Change -7.41% -8.35%
Goodwill $1.265M
YoY Change
Intangibles $78.00K
YoY Change
Long-Term Investments
YoY Change
Other Assets $387.0K $858.0K
YoY Change -54.9% 4.89%
Total Long-Term Assets $43.06M $45.62M
YoY Change -5.61% -5.57%
TOTAL ASSETS
Total Short-Term Assets $10.82M $9.946M
Total Long-Term Assets $43.06M $45.62M
Total Assets $53.89M $55.57M
YoY Change -3.03% -4.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.130M $446.0K
YoY Change 153.36% 8.52%
Accrued Expenses $2.388M $2.021M
YoY Change 18.16% 32.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.251M $1.981M
YoY Change -36.85% -8.67%
Total Short-Term Liabilities $8.679M $8.597M
YoY Change 0.95% -2.35%
LONG-TERM LIABILITIES
Long-Term Debt $4.040M $2.502M
YoY Change 61.47% -4.43%
Other Long-Term Liabilities $986.0K $1.300M
YoY Change -24.15% 195.45%
Total Long-Term Liabilities $4.040M $2.502M
YoY Change 61.47% -4.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.679M $8.597M
Total Long-Term Liabilities $4.040M $2.502M
Total Liabilities $12.72M $11.10M
YoY Change 14.6% -2.83%
SHAREHOLDERS EQUITY
Retained Earnings $7.937M $8.197M
YoY Change -3.17% 8.57%
Common Stock $17.59M $17.31M
YoY Change 1.58% 1.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.52M $25.51M
YoY Change
Total Liabilities & Shareholders Equity $53.89M $55.57M
YoY Change -3.03% -4.32%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$483.0K $31.00K
YoY Change -1658.06% -89.2%
Depreciation, Depletion And Amortization $1.671M $2.023M
YoY Change -17.4% 20.42%
Cash From Operating Activities $3.452M $1.913M
YoY Change 80.45% -34.71%
INVESTING ACTIVITIES
Capital Expenditures -$47.00K -$474.0K
YoY Change -90.08% 63.45%
Acquisitions
YoY Change
Other Investing Activities -$1.568M $0.00
YoY Change
Cash From Investing Activities -$1.615M -$474.0K
YoY Change 240.72% 63.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -451.0K -1.582M
YoY Change -71.49% -16.74%
NET CHANGE
Cash From Operating Activities 3.452M 1.913M
Cash From Investing Activities -1.615M -474.0K
Cash From Financing Activities -451.0K -1.582M
Net Change In Cash 1.386M -143.0K
YoY Change -1069.23% -119.32%
FREE CASH FLOW
Cash From Operating Activities $3.452M $1.913M
Capital Expenditures -$47.00K -$474.0K
Free Cash Flow $3.499M $2.387M
YoY Change 46.59% -25.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000744825
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-08789
dei Entity Registrant Name
EntityRegistrantName
American Shared Hospital Services
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-2918118
dei Entity Address Address Line1
EntityAddressAddressLine1
Two Embarcadero Center,
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 410
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94111
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
788-5300
dei Security12b Title
Security12bTitle
American Shared Hospital Services Common Stock, No Par Value
dei Trading Symbol
TradingSymbol
AMS
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5691000 shares
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4045000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1429000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
364000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
350000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5472000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6894000 USD
CY2020Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
168000 USD
CY2019Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
169000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
774000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1900000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
10823000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
10742000 USD
CY2020Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
94200000 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
99054000 USD
CY2019Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
92132000 USD
CY2020Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
604000 USD
CY2019Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
594000 USD
CY2020Q2 ams Deposits And Construction In Progress Gross
DepositsAndConstructionInProgressGross
4250000 USD
CY2019Q4 ams Deposits And Construction In Progress Gross
DepositsAndConstructionInProgressGross
4215000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
96941000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58753000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
55461000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40301000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41480000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
1265000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
0 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1031000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1106000 USD
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
78000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
387000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
455000 USD
CY2020Q2 us-gaap Assets
Assets
53885000 USD
CY2019Q4 us-gaap Assets
Assets
53783000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1130000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
557000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
418000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
234000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1682000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1779000 USD
CY2020Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
185000 USD
CY2019Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
130000 USD
CY2020Q2 ams Working Capital Payment Due
WorkingCapitalPaymentDue
869000 USD
CY2019Q4 ams Working Capital Payment Due
WorkingCapitalPaymentDue
0 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
288000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
279000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1251000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1526000 USD
CY2020Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2856000 USD
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3709000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8679000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8214000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
743000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
827000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4040000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1954000 USD
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
6785000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
8177000 USD
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
243000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
286000 USD
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2422000 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
10753000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
10753000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6834000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
6725000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2514000 USD
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
7937000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8555000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
25524000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
26033000 USD
CY2020Q2 us-gaap Minority Interest
MinorityInterest
5449000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
5778000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30973000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31811000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53885000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53783000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3991000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5197000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8559000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8559000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10518000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10518000 USD
CY2020Q2 us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
553000 USD
CY2019Q2 us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
652000 USD
us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
1186000 USD
us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
1186000 USD
us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
1320000 USD
us-gaap Direct Operating Maintenance Supplies Costs
DirectOperatingMaintenanceSuppliesCosts
1320000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1637000 USD
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2008000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3284000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3284000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3902000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3902000 USD
CY2020Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
894000 USD
CY2019Q2 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
808000 USD
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
1788000 USD
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
1788000 USD
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
1630000 USD
us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
1630000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
3084000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
3468000 USD
us-gaap Costs And Expenses
CostsAndExpenses
6258000 USD
us-gaap Costs And Expenses
CostsAndExpenses
6852000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
907000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
1729000 USD
us-gaap Gross Profit
GrossProfit
2301000 USD
us-gaap Gross Profit
GrossProfit
2301000 USD
us-gaap Gross Profit
GrossProfit
3666000 USD
us-gaap Gross Profit
GrossProfit
3666000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1210000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1081000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2421000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2421000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2136000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2136000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
267000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
346000 USD
us-gaap Interest Expense
InterestExpense
549000 USD
us-gaap Interest Expense
InterestExpense
549000 USD
us-gaap Interest Expense
InterestExpense
713000 USD
us-gaap Interest Expense
InterestExpense
713000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-570000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
302000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-669000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-669000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
817000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
817000 USD
CY2020Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
1000 USD
CY2019Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
4000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
4000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
4000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
8000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
8000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-569000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
306000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-665000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-665000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
825000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
825000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-130000 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-158000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-158000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
151000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
151000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-439000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
279000 USD
us-gaap Profit Loss
ProfitLoss
-507000 USD
us-gaap Profit Loss
ProfitLoss
-507000 USD
us-gaap Profit Loss
ProfitLoss
674000 USD
us-gaap Profit Loss
ProfitLoss
674000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
44000 USD
CY2019Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
248000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
111000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
111000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
373000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
373000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-483000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
31000 USD
us-gaap Net Income Loss
NetIncomeLoss
-618000 USD
us-gaap Net Income Loss
NetIncomeLoss
-618000 USD
us-gaap Net Income Loss
NetIncomeLoss
301000 USD
us-gaap Net Income Loss
NetIncomeLoss
301000 USD
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31048000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
55000 USD
CY2019Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
19000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
395000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31479000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
102000 shares
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
53000 USD
CY2019Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
57000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
279000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31754000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31811000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
56000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
326000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-68000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31473000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
3000 shares
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
53000 USD
CY2020Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
114000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-439000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
30973000 USD
us-gaap Profit Loss
ProfitLoss
-507000 USD
us-gaap Profit Loss
ProfitLoss
674000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3347000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3933000 USD
ams Non Cash Lease Expense
NonCashLeaseExpense
143000 USD
ams Non Cash Lease Expense
NonCashLeaseExpense
124000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-158000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
109000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
108000 USD
ams Net Accrued Interest On Lease Financing
NetAccruedInterestOnLeaseFinancing
0 USD
ams Net Accrued Interest On Lease Financing
NetAccruedInterestOnLeaseFinancing
-9000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
39000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
40000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2288000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1305000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1206000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-618000 USD
ams Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue
-638000 USD
ams Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue
-176000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-82000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
ams Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-182000 USD
ams Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-164000 USD
ams Increase Decrease In Other Receivable Insurance Settlements
IncreaseDecreaseInOtherReceivableInsuranceSettlements
0 USD
ams Increase Decrease In Other Receivable Insurance Settlements
IncreaseDecreaseInOtherReceivableInsuranceSettlements
-160000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6841000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4373000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
242000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
746000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1568000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1810000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-746000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1062000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
977000 USD
ams Repayments Of Long Term Finance Lease Obligations
RepaymentsOfLongTermFinanceLeaseObligations
1981000 USD
ams Repayments Of Long Term Finance Lease Obligations
RepaymentsOfLongTermFinanceLeaseObligations
2110000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
343000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
440000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
76000 USD
ams Proceeds From Financing For Acquisition
ProceedsFromFinancingForAcquisition
1425000 USD
ams Proceeds From Financing For Acquisition
ProceedsFromFinancingForAcquisition
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2401000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3163000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2630000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
464000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1779000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1792000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4409000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2256000 USD
us-gaap Interest Paid Net
InterestPaidNet
549000 USD
ams Payments For Working Capital
PaymentsForWorkingCapital
515000 USD
us-gaap Interest Paid Net
InterestPaidNet
713000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
71000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
384000 USD
ams Lease Reassessment Right Of Use Assets And Lease Liabilities
LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities
67000 USD
ams Lease Reassessment Right Of Use Assets And Lease Liabilities
LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities
0 USD
ams Non Cash Right Of Use Assets And Lease Liabilities
NonCashRightOfUseAssetsAndLeaseLiabilities
135000 USD
ams Non Cash Right Of Use Assets And Lease Liabilities
NonCashRightOfUseAssetsAndLeaseLiabilities
1362000 USD
ams Interest Capitalized To Property And Equipment
InterestCapitalizedToPropertyAndEquipment
65000 USD
ams Interest Capitalized To Property And Equipment
InterestCapitalizedToPropertyAndEquipment
54000 USD
ams Acquisition Of Equipment With Long Term Debt Financing
AcquisitionOfEquipmentWithLongTermDebtFinancing
1184000 USD
ams Acquisition Of Insurance With Short Term Financing
AcquisitionOfInsuranceWithShortTermFinancing
45000 USD
ams Subsequent Working Capital Payment Accrued For Acquisition
SubsequentWorkingCapitalPaymentAccruedForAcquisition
354000 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
99054000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
96941000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58753000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
55461000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40301000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41480000 USD
CY2020Q2 ams Number Of Debt Instruments
NumberOfDebtInstruments
7 note
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
5291000 USD
CY2020Q2 ams Number Of Financing Leases
NumberOfFinancingLeases
7 lease
CY2020Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
9641000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1031000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1031000 USD
ams Lease Reassessment Right Of Use Assets And Lease Liabilities
LeaseReassessmentRightOfUseAssetsAndLeaseLiabilities
67000 USD
ams Non Cash Right Of Use Assets And Lease Liabilities
NonCashRightOfUseAssetsAndLeaseLiabilities
135000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
171000 USD
CY2020Q2 ams Lessee Operating Lease Liability Payments Due Year One
LesseeOperatingLeaseLiabilityPaymentsDueYearOne
347000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
353000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
248000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1127000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
96000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1031000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-483000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
31000 USD
us-gaap Net Income Loss
NetIncomeLoss
-618000 USD
us-gaap Net Income Loss
NetIncomeLoss
301000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6008000 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5876000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6066000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5862000 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
69000 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
30000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
69000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
33000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6077000 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5906000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6135000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5895000 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
ams Sharebased Compensation Arrangementby Sharebased Payment Award Options Forfeituresin Period Intrinsic Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresinPeriodIntrinsicValue
0 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
53000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
109000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
53000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
108000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
108000 USD
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
434000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
450000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.78
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y5M8D
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
27000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.88
ams Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodOutstandingWeightedAverageRemainingContractualTerm
P7Y
ams Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Intrinsic Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodIntrinsicValue
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
40000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.58
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M4D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
420000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.78
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y1M13D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
397000 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.81
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y11M4D
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
613000 shares
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.85
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
18000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.91
ams Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodOutstandingWeightedAverageRemainingContractualTerm
P7Y
ams Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Intrinsic Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodIntrinsicValue
0 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
16000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
12000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.05
ams Sharebased Compensation Arrangementby Sharebased Payment Award Options Forfeituresin Period Intrinsic Value
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresinPeriodIntrinsicValue
0 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
603000 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.86
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y4M2D
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
57000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
477000 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.87
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y2M19D
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD

Files In Submission

Name View Source Status
report.css Edgar Link pending
0000744825-20-000093-index-headers.html Edgar Link pending
0000744825-20-000093-index.html Edgar Link pending
0000744825-20-000093.txt Edgar Link pending
0000744825-20-000093-xbrl.zip Edgar Link pending
ams-20200630.htm Edgar Link pending
ams-20200630.xsd Edgar Link pending
ams-20200630_cal.xml Edgar Link unprocessable
ams-20200630_def.xml Edgar Link unprocessable
ams-20200630_htm.xml Edgar Link completed
ams-20200630_lab.xml Edgar Link unprocessable
ams-20200630_pre.xml Edgar Link unprocessable
ams06-30x2020xex312.htm Edgar Link pending
ams06-30x2020xex321.htm Edgar Link pending
ams06-30x2020xexx311.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
firstamendmentleaserev.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
Show.js Edgar Link pending